2-Arylbenzothiazole as a Privileged Scaffold in Drug Discovery

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|16|19|2430-2440

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.19, 2009-07, pp. : 2430-2440

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rhodanine as a Privileged Scaffold in Drug Discovery

By  

Current Medicinal Chemistry, Vol. 16, Iss. 13, 2009-05 ,pp. : 1596-1629

Bentham Science Publishers

Access to resources Recommend Favorite

Quinoline as a Privileged Scaffold in Cancer Drug Discovery

By  

Current Medicinal Chemistry, Vol. 18, Iss. 10, 2011-04 ,pp. : 1488-1508

Bentham Science Publishers

Access to resources Recommend Favorite

From Nature to Drug Discovery: The Indole Scaffold as a ‘Privileged Structure’

By  

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 7, 2009-06 ,pp. : 782-793

Bentham Science Publishers

Access to resources Recommend Favorite

Benzimidazoles: An Ideal Privileged Drug Scaffold for the Design of Multitargeted Anti-inflammatory Ligands

By  

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 9, 2014-07 ,pp. : 747-767

Bentham Science Publishers

Access to resources Recommend Favorite

2-Arylindoles: A Privileged Molecular Scaffold with Potent, Broad-Ranging Pharmacological Activity

By  

Current Medicinal Chemistry, Vol. 19, Iss. 28, 2012-10 ,pp. : 4828-4837

Bentham Science Publishers

Access to resources Recommend Favorite